Drug intelligence / Profile preview

Acufal-Plus

Development stage
Unknown
Lead developer
Acure Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Acufal-Plus is a multi-ingredient nutraceutical combination supplement developed by Acure Pharma, an Indian pharmaceutical company. Formulated as an oral tablet, it contains a synergistic blend of active vitamins and nutrients, including L-methylfolate (the active form of folate), methylcobalamin (vitamin B12), pyridoxal 5-phosphate (the active form of vitamin B6), vitamin D3 (cholecalciferol), and docosahexaenoic acid (DHA), along with biotin and choline. The supplement is designed to support the one-carbon/folate metabolic pathways, activate the vitamin D receptor, and provide essential omega-3 fatty acids. It is primarily indicated for nutritional supplementation and the treatment or prevention of folate, vitamin B12, and vitamin D deficiencies, thereby supporting metabolic and neurological health. The product is currently approved and marketed in India.

Brand names
Acufal-PlusAcufol Plus
Other names
L-Methyl Folate + Methylcobalamin + Pyridoxal 5-Phosphate + Vitamin D3 + DHAL-Methylfolate + Methylcobalamin + Pyridoxal 5-Phosphate + Cholecalciferol + Docosahexaenoic Acid
02

Targets

MTR (Methionine synthase)MTHFR (Methylenetetrahydrofolate reductase)VDR (Vitamin D receptor)FFAR4 (Free fatty acid receptor 4)

Beyond the preview

Go deeper on Acufal-Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acufal-Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call